Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems ; day:1 ; month:11 ; year:2023 ; pages:1-9
Pharmaceutical research ; (1.11.2023), 1-9
- Urheber
-
Luo, Shen
Zhang, Baolin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-023-03628-4
- URN
-
urn:nbn:de:101:1-2024011821041266394532
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Luo, Shen
- Zhang, Baolin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments
Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments
Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments